Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study

Archive ouverte

Babich, Tanya | Naucler, Pontus | Valik, John Karlsson | Giske, Christian | Benito, Natividad | Cardona, Ruben | Rivera, Alba | Pulcini, Céline | Fattah, Manal Abdel | Haquin, Justine | Macgowan, Alasdair | Grier, Sally | Chazan, Bibiana | Yanovskay, Anna | Ami, Ronen Ben | Landes, Michal | Nesher, Lior | Zaidman-Shimshovitz, Adi | Mccarthy, Kate | Paterson, David | Tacconelli, Evelina | Buhl, Michael | Mauer, Susanna | Rodríguez-Baño, Jesús | Morales, Isabel | Oliver, Antonio | de Gopegui, Enrique Ruiz | Cano, Angela | Machuca, Isabel | Gozalo-Marguello, Monica | Martínez-Martínez, Luis | Gonzalez-Barbera, Eva | Alfaro, Iris Gomez | Salavert, Miguel | Beovic, Bojana | Saje, Andreja | Mueller-Premru, Manica | Pagani, Leonardo | Vitrat, Virginie | Kofteridis, Diamantis | Zacharioudaki, Maria | Maraki, Sofia | Weissman, Yulia | Paul, Mical | Dickstein, Yaakov | Leibovici, Leonard | Yahav, Dafna

Edité par CCSD ; Elsevier -

International audience. This study aimed to evaluate risk factors for 30-day mortality among hospitalised patients with Pseudomonas aeruginosa bacteraemia, a highly fatal condition. A retrospective study was conducted between 1 January 2009 and 31 October 2015 in 25 centres (9 countries) including 2396 patients. Univariable and multivariable analyses of risk factors were conducted for the entire cohort and for patients surviving ≥48 h. A propensity score for predictors of appropriate empirical therapy was introduced into the analysis. Of the 2396 patients, 636 (26.5%) died within 30 days. Significant predictors (odds ratio and 95% confidence interval) of mortality in the multivariable analysis included patient-related factors: age (1.02, 1.01-1.03); female sex (1.34, 1.03-1.77); bedridden functional capacity (1.99, 1.24-3.21); recent hospitalisation (1.43, 1.07-1.92); concomitant corticosteroids (1.33, 1.02-1.73); and Charlson comorbidity index (1.05, 1.01-1.93). Infection-related factors were multidrug-resistant Pseudomonas (1.52, 1.15-2.1), non-urinary source (2.44, 1.54-3.85) and Sequential Organ Failure Assessment (SOFA) score (1.27, 1.18-1.36). Inappropriate empirical therapy was not associated with increased mortality (0.81, 0.49-1.33). Among 2135 patients surviving ≥48 h, hospital-acquired infection (1.59, 1.21-2.09), baseline endotracheal tube (1.63, 1.13-2.36) and ICU admission (1.53, 1.02-2.28) were additional risk factors. Risk factors for mortality among patients with P. aeruginosa were mostly irreversible. Early appropriate empirical therapy was not associated with reduced mortality. Further research should be conducted to explore subgroups that may not benefit from broad-spectrum antipseudomonal empirical therapy. Efforts should focus on prevention of infection, mainly hospital-acquired infection and multidrug-resistant pseudomonal infection.

Consulter en ligne

Suggestions

Du même auteur

Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study

Archive ouverte | Babich, Tanya | CCSD

International audience

Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study

Archive ouverte | Babich, Tanya | CCSD

International audience. BACKGROUND: The optimal antibiotic regimen for Pseudomonas aeruginosa bacteremia is controversial. Though beta-lactam monotherapy is common, data to guide the choice between antibiotics are s...

Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study

Archive ouverte | Babich, Tanya | CCSD

International audience. Abstract Background Pseudomonas aeruginosa bacteraemia is a common and serious infection. No consensus exists regarding whether definitive combination therapy is superior to monotherapy. We a...

Chargement des enrichissements...